Literatur
-
1
Antman E M, Cohen M, Radley D. et al .
Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis.
Circulation.
1999;
100
1602-1608
-
2
Boersma E, Harrington R A, Moliterno D J. et al .
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.
Lancet.
2002;
359
189-198
-
3
Cannon C P, Weintraub W S, Demopoulos L A. et al .
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
N Engl J Med.
2001;
344
1879-1887
-
4
CAPRIE Steering Committee .
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).
Lancet.
1996;
348
1329-1339
-
5
Eikelboom J W, Anand S S, Malmberg K. et al .
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis.
Lancet.
2000;
355
1936-1942
-
6
FRISC II Investigators .
Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators.
Lancet.
1999;
354
708-715
-
7
GUSTO Investigators .
A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators.
N Engl J Med.
1996;
335
775-782
-
8
Mehta S R, Yusuf S, Peters R J. et al .
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
Lancet.
2001;
358
527-533
-
9
OASIS Investigators .
Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators.
J Am Coll Cardiol.
2001;
37
475-484
-
10
OASIS Investigators .
Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
Lancet.
1999;
353
429-438
-
11
Oler A, Whooley M A, Oler J, Grady D.
Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis.
JAMA.
1996;
276
811-815
-
12
Simoons M L.
Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial.
Lancet.
2001;
357
1915-1924
-
13
Steinhubl S R, Berger P, Mann J T. et al .
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.
JAMA.
2002;
288
2411-2420
-
14
Trialists`Collaboration .
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
BMJ.
2002;
324
71-86
-
15
Topol E J, Moliterno D J, Herrmann H C. et al .
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
N Engl J Med.
2001;
344
1888-1894
-
16
Yusuf S, Zhao F, Mehta S R. et al .
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
N Engl J Med.
2001;
345
494-502
Dr. med. Michael Weber
Abteilung für Kardiologie, Kerckhoff Klinik
Benekestraße 2-8
61231 Bad Nauheim
eMail: Michael.Weber@kerckhoff.med.uni-giessen.de
